Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Globus Medical Inc (NY: GMED )

84.91 +1.32 (+1.58%)
Official Closing Price Updated: 7:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Globus Medical Inc

< Previous 1 2 3 4 5 6 Next >
Despite its growth, NYSE:GMED remains within the realm of affordability.
GLOBUS MEDICAL INC - A (NYSE:GMED) stands out as a growth opportunity that won't break the bank. 
Via Chartmill
What 7 Analyst Ratings Have To Say About Globus Medical
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
CVS Health, Johnson Controls And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
Globus Medical (GMED) Q3 2024 Earnings Call Transcript
GMED earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
The Analyst Verdict: Globus Medical In The Eyes Of 7 Experts
Via Benzinga
NYSE:GMED is showing good growth, while it is not too expensive.
In the world of growth stocks, NYSE:GMED shines as a value proposition. 
Via Chartmill
Looking Into Globus Medical's Recent Short Interest
Via Benzinga
A Glimpse Into The Expert Outlook On Globus Medical Through 8 Analysts
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
While growth is established for NYSE:GMED, the stock's valuation remains reasonable.
While growth is established for NYSE:GMED, the stock's valuation remains reasonable. 
Via Chartmill
Investors should take note of NYSE:GMED, a growth stock that remains attractively priced.
GLOBUS MEDICAL INC - A (NYSE:GMED) stands out as a growth opportunity that won't break the bank. 
Via Chartmill
Looking Into Globus Medical's Recent Short Interest
Via Benzinga
What 8 Analyst Ratings Have To Say About Globus Medical
Via Benzinga
Globus Medical (GMED) Q2 2024 Earnings Call Transcript
GMED earnings call for the period ending June 30, 2024. 
Via The Motley Fool
Topics Earnings
Exposures Financial
NYSE:GMED is showing decent growth, but is still valued reasonably.
NYSE:GMED, a growth stock which is not overvalued. 
Via Chartmill
Peering Into Globus Medical's Recent Short Interest
Via Benzinga
Where Globus Medical Stands With Analysts
Via Benzinga
GMED Stock Earnings: Globus Medical Beats EPS, Beats Revenue for Q2 2024
GMED stock results show that Globus Medical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
For those who appreciate growth without the sticker shock, NYSE:GMED is worth considering.
GLOBUS MEDICAL INC - A (NYSE:GMED) is showing decent growth, but is still valued reasonably. 
Via Chartmill
Staar Surgical Stock Earns RS Rating Upgrade
On Thursday, lens maker Staar Surgical stock had its Relative Strength (RS) Rating upgraded to 87 from 77. 
Via Investor's Business Daily
NYSE:GMED is not too expensive for the growth it is showing.
Looking for growth without the hefty price tag? Consider NYSE:GMED. 
Via Chartmill
Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React
U.S. inflation slowed in May, boosting rate cut prospects. Markets rally ahead of FOMC meeting and assign 70% chance of rate cut in September. 
Via Benzinga
Topics Economy
Exposures Interest Rates
Deep Dive Into Globus Medical Stock: Analyst Perspectives (7 Ratings)
Via Benzinga
Key Takeaways From Globus Medical Analyst Ratings
Via Benzinga
Stryker Stock Sees RS Rating Treks Higher To 71
Stryker stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, with an increase from 63 to 71. 
Via Investor's Business Daily
CrowdStrike To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Don't overlook NYSE:GMED—a stock with solid growth prospects and a reasonable valuation.
Looking for growth without the hefty price tag? Consider GLOBUS MEDICAL INC - A (NYSE:GMED). 
Via Chartmill
This Micron Technology Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Today
Via Benzinga
Globus Medical Shares Race Higher After Better-Than-Expected Q1 Results
Globus Medical reported quarterly earnings of 72 cents per share which beat the analyst consensus estimate of 57 cents by 26.32% and represents a 35.85% increase over earnings from the same period last... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.